The usefulness of Charlson Comorbidity Index (CCI) scoring in predicting all-cause mortality in Outpatients with Clinical Diagnoses of COPD

Background Since comorbid conditions are frequently present in chronic obstructive pulmonary disease (COPD) and affect outcome, a composite scoring system to quantify comorbidity might be helpful in assessing mortality risk. Methods We tested the hypothesis that the Charlson Comorbidity Index (CCI)...

Full description

Saved in:
Bibliographic Details
Main Authors: Kevin Ly, Dorothy Wakefield, Richard ZuWallack
Format: Article
Language:English
Published: SAGE Publishing 2025-01-01
Series:Journal of Multimorbidity and Comorbidity
Online Access:https://doi.org/10.1177/26335565251315876
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832584119594254336
author Kevin Ly
Dorothy Wakefield
Richard ZuWallack
author_facet Kevin Ly
Dorothy Wakefield
Richard ZuWallack
author_sort Kevin Ly
collection DOAJ
description Background Since comorbid conditions are frequently present in chronic obstructive pulmonary disease (COPD) and affect outcome, a composite scoring system to quantify comorbidity might be helpful in assessing mortality risk. Methods We tested the hypothesis that the Charlson Comorbidity Index (CCI) score at the time of an outpatient medical clinic encounter for COPD predicts all-cause mortality. Cox Proportional Hazards analyses were used in 200 randomly selected patients to relate CCI scores to all-cause mortality out to 5 years. Results Mean age was 62 ± 10 years, 56% were female, FEV1 was 62%, CCI was 3.08 ± 2.30, and 30% had a CCI ≥ 4, indicating 3 or more comorbid conditions. All-cause mortality was 8.5% and 20% at 3 and 5 years, respectively. In univariate testing, the CCI score and hospitalizations predicted mortality, but FEV1 did not. In multivariable testing, which included covariates of age, sex, socioeconomic status, race, FEV1 percent-predicted, and all-cause hospitalizations in the preceding year, CCI expressed as a continuous variable strongly predicted mortality: hazard ratio (HR) 1.38 for each unit increase in the score (p < 0.0001). While 1 or 2 comorbid conditions were not significantly related to mortality, 3 or more comorbid conditions (compared to none) strongly predicted mortality: HR 9.80, 95% CI 3.80 to 25.00. Conclusion Comorbidity, assessed with the CCI, is strongly predictive of mortality in outpatients with a clinical diagnosis of COPD, and this relationship appears to be non-linear. This instrument may be useful in determining prognosis in this population.
format Article
id doaj-art-85cef1efb1f54179b4a7a95acb60490a
institution Kabale University
issn 2633-5565
language English
publishDate 2025-01-01
publisher SAGE Publishing
record_format Article
series Journal of Multimorbidity and Comorbidity
spelling doaj-art-85cef1efb1f54179b4a7a95acb60490a2025-01-27T16:03:31ZengSAGE PublishingJournal of Multimorbidity and Comorbidity2633-55652025-01-011510.1177/26335565251315876The usefulness of Charlson Comorbidity Index (CCI) scoring in predicting all-cause mortality in Outpatients with Clinical Diagnoses of COPDKevin LyDorothy WakefieldRichard ZuWallackBackground Since comorbid conditions are frequently present in chronic obstructive pulmonary disease (COPD) and affect outcome, a composite scoring system to quantify comorbidity might be helpful in assessing mortality risk. Methods We tested the hypothesis that the Charlson Comorbidity Index (CCI) score at the time of an outpatient medical clinic encounter for COPD predicts all-cause mortality. Cox Proportional Hazards analyses were used in 200 randomly selected patients to relate CCI scores to all-cause mortality out to 5 years. Results Mean age was 62 ± 10 years, 56% were female, FEV1 was 62%, CCI was 3.08 ± 2.30, and 30% had a CCI ≥ 4, indicating 3 or more comorbid conditions. All-cause mortality was 8.5% and 20% at 3 and 5 years, respectively. In univariate testing, the CCI score and hospitalizations predicted mortality, but FEV1 did not. In multivariable testing, which included covariates of age, sex, socioeconomic status, race, FEV1 percent-predicted, and all-cause hospitalizations in the preceding year, CCI expressed as a continuous variable strongly predicted mortality: hazard ratio (HR) 1.38 for each unit increase in the score (p < 0.0001). While 1 or 2 comorbid conditions were not significantly related to mortality, 3 or more comorbid conditions (compared to none) strongly predicted mortality: HR 9.80, 95% CI 3.80 to 25.00. Conclusion Comorbidity, assessed with the CCI, is strongly predictive of mortality in outpatients with a clinical diagnosis of COPD, and this relationship appears to be non-linear. This instrument may be useful in determining prognosis in this population.https://doi.org/10.1177/26335565251315876
spellingShingle Kevin Ly
Dorothy Wakefield
Richard ZuWallack
The usefulness of Charlson Comorbidity Index (CCI) scoring in predicting all-cause mortality in Outpatients with Clinical Diagnoses of COPD
Journal of Multimorbidity and Comorbidity
title The usefulness of Charlson Comorbidity Index (CCI) scoring in predicting all-cause mortality in Outpatients with Clinical Diagnoses of COPD
title_full The usefulness of Charlson Comorbidity Index (CCI) scoring in predicting all-cause mortality in Outpatients with Clinical Diagnoses of COPD
title_fullStr The usefulness of Charlson Comorbidity Index (CCI) scoring in predicting all-cause mortality in Outpatients with Clinical Diagnoses of COPD
title_full_unstemmed The usefulness of Charlson Comorbidity Index (CCI) scoring in predicting all-cause mortality in Outpatients with Clinical Diagnoses of COPD
title_short The usefulness of Charlson Comorbidity Index (CCI) scoring in predicting all-cause mortality in Outpatients with Clinical Diagnoses of COPD
title_sort usefulness of charlson comorbidity index cci scoring in predicting all cause mortality in outpatients with clinical diagnoses of copd
url https://doi.org/10.1177/26335565251315876
work_keys_str_mv AT kevinly theusefulnessofcharlsoncomorbidityindexcciscoringinpredictingallcausemortalityinoutpatientswithclinicaldiagnosesofcopd
AT dorothywakefield theusefulnessofcharlsoncomorbidityindexcciscoringinpredictingallcausemortalityinoutpatientswithclinicaldiagnosesofcopd
AT richardzuwallack theusefulnessofcharlsoncomorbidityindexcciscoringinpredictingallcausemortalityinoutpatientswithclinicaldiagnosesofcopd
AT kevinly usefulnessofcharlsoncomorbidityindexcciscoringinpredictingallcausemortalityinoutpatientswithclinicaldiagnosesofcopd
AT dorothywakefield usefulnessofcharlsoncomorbidityindexcciscoringinpredictingallcausemortalityinoutpatientswithclinicaldiagnosesofcopd
AT richardzuwallack usefulnessofcharlsoncomorbidityindexcciscoringinpredictingallcausemortalityinoutpatientswithclinicaldiagnosesofcopd